{
    "eid": "2-s2.0-85149153248",
    "title": "Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors?",
    "cover-date": "2023-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cribriform",
        "intraductal carcinoma",
        "pathology",
        "prostate cancer",
        "WHO classification"
    ],
    "authors": [
        "Jerasit Surintrspanont",
        "Ming Zhou"
    ],
    "citedby-count": 0,
    "ref-count": 82,
    "ref-list": [
        "Forewards with changes from the book, including corrigenda",
        "Tumours of the prostate: Introduction",
        "Chapter 1: Introduction to urinary and male genital tumours",
        "Prostatic acinar adenocarcinoma",
        "Prostatic ductal adenocarcinoma",
        "The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System",
        "Prognostic Gleason grade grouping: data based on the modified Gleason scoring system",
        "Adenoid cystic (basal cell) carcinoma of the prostate",
        "MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia",
        "MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma",
        "Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features",
        "TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas",
        "PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas",
        "Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate",
        "Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations",
        "Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer",
        "A Japanese patient with ductal carcinoma of the prostate carrying an adenomatosis polyposis coli gene mutation: a case report",
        "Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management",
        "High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases",
        "PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations",
        "Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care",
        "High-grade prostatic intraepithelial neoplasia",
        "Precursor lesions to prostatic adenocarcinoma",
        "High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate",
        "Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy",
        "Atypical intraductal proliferation detected in prostate needle biopsy is a marker of unsampled intraductal carcinoma and other adverse pathological features: a prospective clinicopathological study of 62 cases with emphasis on pathological outcomes",
        "Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma",
        "Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate",
        "The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer",
        "Intraductal carcinoma of the prostate",
        "Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations",
        "Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance",
        "A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma",
        "Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives",
        "Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019",
        "Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer",
        "Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer",
        "The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma",
        "Head to head: should the intraductal component of invasive prostate cancer be graded?",
        "Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations",
        "On cribriform prostate cancer",
        "The New Realization About Cribriform Prostate Cancer",
        "Spectrum of Cribriform Proliferations of the Prostate: From Benign to Malignant",
        "Historical and contemporary perspectives on cribriform morphology in prostate cancer",
        "Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma",
        "Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis",
        "Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy",
        "Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort",
        "ISUP Consensus Definition of Cribriform Pattern Prostate Cancer",
        "Diagnosis of \u201ccribriform\u201d prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations",
        "Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome",
        "Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3+4=7 prostate cancer",
        "Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists",
        "Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome",
        "Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3+4=7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy",
        "Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort",
        "Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies",
        "Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25mm diameter as an optimal definition for \u201clarge\u201d cribriform prostatic adenocarcinoma",
        "Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer",
        "Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer",
        "Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage",
        "Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers",
        "Clinical features of neuroendocrine prostate cancer",
        "Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis",
        "Neuroendocrine tumors of genitourinary tract: Recent advances",
        "Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives",
        "Variant of prostatic adenocarcinoma with Paneth cell\u2013like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5",
        "Neuroendocrine tumors of the prostate",
        "Mechanisms of prostate cancer initiation and progression",
        "Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer",
        "Copy number alteration burden predicts prostate cancer relapse",
        "Genomic Markers in Prostate Cancer Decision Making",
        "A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer",
        "Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis",
        "A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer",
        "Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer",
        "Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade",
        "CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors",
        "NCCN Guidelines Insights: Prostate Cancer, Version 1.2021",
        "Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60001344",
            "affilname": "Tufts Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001344",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Genitourinary Pathology Society"
    ]
}